Experts recommend the use of prophylaxis to reduce RSV infection in children with congenital heart diseases
MADRID, 9 (EUROPA PRESS) Measures of respiratory virus infection prophylaxis syncytial (RSV) are themselves necessary, but when it comes to children with congenital heart diseases are vital, because in these patients the condition tends to be more serious to the commit directly the patient’s cardiopulmonary system, explains Constantius Medrano, head of unit Cardiology non invasive Pediatric Hospital General Universitario Gregorio Marañón in Madrid. “Have managed to show that these children should take care of them more and comply with the recommendation of the antibody prophylaxis exists is the palivizumab because its benefits have been proven,” emphasizes this expert in statements to Europe Press. Respiratory syncytial virus infection is the main virus that causes broquiolitis in hospitals and in young children. In the case of children with heart disease this situation interferes with the possible and necessary operations. The problem, he explains, is that “even taking prophylaxis measures not all children meet this recommendation”. “There are special children, as well as those who have some heart disease, such as children with Down’s syndrome or with asthma, which affects to a greater extent”, as they show the results of the CIVIC survey carried out on a sample of more than 2,000 children of 53 Spanish hospitals, where “becomes a good portrait of the infection” and has become an international reference. Study showed that more than 7 percent of revenue in children...
Read More